Inclisiran patent expiry date?

When Does the Exclusivity Expire on Inclisiran?

Inclisiran, a cholesterol-lowering medication, has been gaining attention in the pharmaceutical industry. The drug's developer, Novartis, has been working to maintain its market exclusivity through patents.

According to DrugPatentWatch.com [1], Inclisiran's US patent expires on April 7, 2041, while the European patent expires on December 12, 2042. These expiration dates mark the end of the exclusive manufacturing and sales rights held by Novartis.

However, as the patent expiration approaches, competitors are anticipated to enter the market with biosimilar versions of Inclisiran. These biosimilars, designed to mimic the efficacy of the original drug, could provide cheaper alternatives for patients.

Why Are Companies Challenging the Patents?

Several pharmaceutical companies, like Pfizer, are challenging Inclisiran's patent claims in court, arguing that Novartis's exclusivity is too long and stifles competition. This challenge could lead to a reduction in the patent's scope, allowing more companies to develop biosimilars before the main patent expires.

Impact on Patients

The impending patent expiry on Inclisiran raises questions about the affordability of the medication. With biosimilars expected to enter the market, healthcare providers and patients may be able to access cheaper versions of the drug, making it more accessible to those who cannot afford the brand-name version.

What Happens After Patent Expiry?

Once the patents expire, companies other than Novartis will be able to manufacture and sell biosimilar versions of Inclisiran. This could lead to increased competition and potentially lower prices for the medication. However, the quality of these biosimilars will need to be carefully evaluated to ensure they meet the same safety and efficacy standards as the original Inclisiran.

Citations:

[1] DrugPatentWatch.com. (n.d.). Inclisiran Patent Expiration. https://www.drugpatentwatch.com/declining-approval-for-patents-for-novo-inclisiran-inclisiran-novo-inclisiran